Company
PROK’s -11.43% Loss This Week Has Revealed Something We Didn’t Know Before
During the last session, ProKidney Corp (NASDAQ:PROK)’s traded shares were 0.39 million, with the beta value of the company hitting 1.31. At the end of
Marketing Sentinel delivers exclusive content, news, articles, and comprehensive coverage of events in the USA and worldwide with a commitment to reliability, objectivity, and timeliness.
